ERBB2 and neoplasm: This is consistent with previous findings using in vivo mammary tumorigenesis models that tumor cells with loss of p53 function or overexpression of ErbB2 exhibit increased self-renewal [19], and that activated Ras or over-expression of EGFR inhibit normal mammary gland differentiation [20, 24].